Finch Therapeutics Group

FNCH47

$11.50arrow_drop_down1.62%-$0.19

FNCH47

$11.50

arrow_drop_down1.62%-$0.19

Performance History

Key Stats
Open	$11.65
Prev. Close	$11.69
EPS	-8.80
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$19.34M
PE Ratio	-

	LOW	HIGH
Day Range	11.50	11.65
52 Week Range	0.80	14.26

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-8.80

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Finch Therapeutics Group (FNCH)

Finch Therapeutics Group, Inc. (FNCH) is a biotechnology company that focuses on developing microbiome-based therapeutics for various diseases. The company's goal is to harness the power of the human microbiome, which consists of trillions of microorganisms living in the gut, to treat a range of conditions. By understanding and manipulating the microbiome, Finch Therapeutics aims to create new therapies that can improve the lives of patients.

One of the key areas of focus for Finch Therapeutics is the treatment of Clostridium difficile infection (CDI), a severe and potentially life-threatening infection of the colon. CDI can be caused by the disruption of the natural balance of bacteria in the gut, often due to the use of antibiotics. Finch Therapeutics is developing a microbiome-based therapy called CP101 for the treatment of CDI. CP101 is designed to restore the natural balance of bacteria in the gut and eliminate the infection.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO
Headquarters: Somerville
Employees: 18
Exchange: NASDAQ

add Finch Therapeutics Group to watchlist

Keep an eye on Finch Therapeutics Group

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is the 52-week high and low for Finch Therapeutics Group (FNCH)?

For Finch Therapeutics Group (FNCH), the 52-week high is $14.26, which is 24% from the current price. The 52-week low is $0.8, the current price is 1.34K% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

What is Finch Therapeutics Group's (FNCH) price per share?

The current price per share for Finch Therapeutics Group (FNCH) is $11.5. The stock has seen a price change of -$0.19 recently, indicating a -1.63% change. This reflects the stock's recent market performance and investor sentiment.

help

Is Finch Therapeutics Group (FNCH) a growth stock?

Finch Therapeutics Group (FNCH) has shown an average price growth of -4.13% over the past three years. It has received a score of -6 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Finch Therapeutics Group as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Finch Therapeutics Group (FNCH) stock price performance year to date (YTD)?

As of the latest data, Finch Therapeutics Group (FNCH) has a year-to-date price change of 201.09%. Over the past month, the stock has experienced a price change of -4.17%. Over the last three months, the change has been 0%. Over the past six months, the figure is 480.81%.

help

Is Finch Therapeutics Group (FNCH) a profitable company?

Finch Therapeutics Group (FNCH) has a net income of -$74.75M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$34M. Furthermore, the EBITDA is $17.35M.

help

What is the market capitalization of Finch Therapeutics Group (FNCH)?

Finch Therapeutics Group (FNCH) has a market capitalization of $19.35M. The average daily trading volume is 2.25K, indicating the stock's liquidity and investor engagement.